Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.06%
#3 CoW Protocol CoW Protocol +41.78%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.87%
#6 Codatta Codatta +21.56%
#7 Walrus Walrus +20.27%
#8 Enso Enso +18.27%
#9 The Black Bull The Black Bull +16.62%
#10 Tutorial Tutorial +14.28%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Peringkat dalam Saham #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Harga Saham
$0.117
Terakhir disinkronkan: 2025-04-04
Kapitalisasi Pasar
$2.45M
Perubahan (1 hari)
-13.59%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Carmell Therapeutics Corporation (CTCX)

Kategori

Healthcare
Rasio P/S untuk Carmell Therapeutics Corporation (CTCX)
Rasio P/S per August 2026 TTM: 3.52
Menurut laporan keuangan dan harga saham terbaru dari Carmell Therapeutics Corporation, rasio P/S saat ini (TTM) adalah 3.52. Pada akhir 2023, rasio P/S perusahaan adalah 0.00.
Riwayat rasio P/S untuk Carmell Therapeutics Corporation dari 2021 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 3.52 -99.90%
2024 3.48K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 188.58%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 187.49%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 34.60%
BE